1071 related articles for article (PubMed ID: 31271312)
1. Reduction in HbA1c using professional flash glucose monitoring in insulin-treated type 2 diabetes patients managed in primary and secondary care settings: A pilot, multicentre, randomised controlled trial.
Ajjan RA; Jackson N; Thomson SA
Diab Vasc Dis Res; 2019 Jul; 16(4):385-395. PubMed ID: 31271312
[TBL] [Abstract][Full Text] [Related]
2. Sensor and software use for the glycaemic management of insulin-treated type 1 and type 2 diabetes patients.
Ajjan RA; Abougila K; Bellary S; Collier A; Franke B; Jude EB; Rayman G; Robinson A; Singh BM
Diab Vasc Dis Res; 2016 May; 13(3):211-9. PubMed ID: 27000105
[TBL] [Abstract][Full Text] [Related]
3. Impact of flash glucose monitoring on hypoglycaemia in adults with type 1 diabetes managed with multiple daily injection therapy: a pre-specified subgroup analysis of the IMPACT randomised controlled trial.
Oskarsson P; Antuna R; Geelhoed-Duijvestijn P; Krӧger J; Weitgasser R; Bolinder J
Diabetologia; 2018 Mar; 61(3):539-550. PubMed ID: 29273897
[TBL] [Abstract][Full Text] [Related]
4. Rationale and design of the LIBERATES trial: Protocol for a randomised controlled trial of flash glucose monitoring for optimisation of glycaemia in individuals with type 2 diabetes and recent myocardial infarction.
Everett CC; Reynolds C; Fernandez C; Stocken DD; Sharples LD; Sathyapalan T; Heller S; Storey RF; Ajjan RA
Diab Vasc Dis Res; 2020; 17(5):1479164120957934. PubMed ID: 33081502
[TBL] [Abstract][Full Text] [Related]
5. Efficacy of self-monitoring of blood glucose versus retrospective continuous glucose monitoring in improving glycaemic control in diabetic kidney disease patients.
Yeoh E; Lim BK; Fun S; Tong J; Yeoh LY; Sum CF; Subramaniam T; Lim SC
Nephrology (Carlton); 2018 Mar; 23(3):264-268. PubMed ID: 27933715
[TBL] [Abstract][Full Text] [Related]
6. The impact of flash glucose monitoring on glycated hemoglobin in type 2 diabetes managed with basal insulin in Canada: A retrospective real-world chart review study.
Elliott T; Beca S; Beharry R; Tsoukas MA; Zarruk A; Abitbol A
Diab Vasc Dis Res; 2021; 18(4):14791641211021374. PubMed ID: 34275385
[TBL] [Abstract][Full Text] [Related]
7. Automated insulin dosing guidance to optimise insulin management in patients with type 2 diabetes: a multicentre, randomised controlled trial.
Bergenstal RM; Johnson M; Passi R; Bhargava A; Young N; Kruger DF; Bashan E; Bisgaier SG; Isaman DJM; Hodish I
Lancet; 2019 Mar; 393(10176):1138-1148. PubMed ID: 30808512
[TBL] [Abstract][Full Text] [Related]
8. Impact of blinded retrospective continuous glucose monitoring on clinical decision making and glycemic control in persons with type 2 diabetes on insulin therapy.
Ribeiro RT; Andrade R; Nascimento do Ó D; Lopes AF; Raposo JF
Nutr Metab Cardiovasc Dis; 2021 Apr; 31(4):1267-1275. PubMed ID: 33612381
[TBL] [Abstract][Full Text] [Related]
9. Continuous glucose monitoring with structured education in adults with type 2 diabetes managed by multiple daily insulin injections: a multicentre randomised controlled trial.
Kim JY; Jin SM; Sim KH; Kim BY; Cho JH; Moon JS; Lim S; Kang ES; Park CY; Kim SG; Kim JH
Diabetologia; 2024 Jul; 67(7):1223-1234. PubMed ID: 38639876
[TBL] [Abstract][Full Text] [Related]
10. Novel glucose-sensing technology and hypoglycaemia in type 1 diabetes: a multicentre, non-masked, randomised controlled trial.
Bolinder J; Antuna R; Geelhoed-Duijvestijn P; Kröger J; Weitgasser R
Lancet; 2016 Nov; 388(10057):2254-2263. PubMed ID: 27634581
[TBL] [Abstract][Full Text] [Related]
11. Hypoglycaemia in the over 75s: Understanding the predisposing factors in type 2 diabetes (T2DM).
Heald AH; Anderson SG; Cortes GJ; Cholokova V; Narajos M; Khan A; Donnahey G; Livingston M
Prim Care Diabetes; 2018 Apr; 12(2):133-138. PubMed ID: 28941578
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of an mHealth-enabled hierarchical diabetes management intervention in primary care in China (ROADMAP): A cluster randomized trial.
Jia W; Zhang P; Zhu D; Duolikun N; Li H; Bao Y; Li X;
PLoS Med; 2021 Sep; 18(9):e1003754. PubMed ID: 34547030
[TBL] [Abstract][Full Text] [Related]
13. Efficacy of flash glucose monitoring in pregnant women with poorly controlled pregestational diabetes (FlashMom): A randomized pilot study.
Tumminia A; Milluzzo A; Festa C; Fresa R; Pintaudi B; Scavini M; Vitacolonna E; Napoli A; Sciacca L
Nutr Metab Cardiovasc Dis; 2021 Jun; 31(6):1851-1859. PubMed ID: 33975741
[TBL] [Abstract][Full Text] [Related]
14. Makes FLASH the difference between the intervention group and the treatment-as-usual group in an evaluation study of a structured education and treatment programme for flash glucose monitoring devices in people with diabetes on intensive insulin therapy: study protocol for a randomised controlled trial.
Schipfer M; Albrecht C; Ehrmann D; Haak T; Kulzer B; Hermanns N
Trials; 2018 Feb; 19(1):91. PubMed ID: 29402319
[TBL] [Abstract][Full Text] [Related]
15. Liraglutide in people treated for type 2 diabetes with multiple daily insulin injections: randomised clinical trial (MDI Liraglutide trial).
Lind M; Hirsch IB; Tuomilehto J; Dahlqvist S; Ahrén B; Torffvit O; Attvall S; Ekelund M; Filipsson K; Tengmark BO; Sjöberg S; Pehrsson NG
BMJ; 2015 Oct; 351():h5364. PubMed ID: 26512041
[TBL] [Abstract][Full Text] [Related]
16. Real-world outcomes with different technology modalities in type 1 diabetes.
Beato-Víbora PI; Gallego-Gamero F; Ambrojo-López A
Nutr Metab Cardiovasc Dis; 2021 Jun; 31(6):1845-1850. PubMed ID: 33838993
[TBL] [Abstract][Full Text] [Related]
17. A randomized controlled pilot study of continuous glucose monitoring and flash glucose monitoring in people with Type 1 diabetes and impaired awareness of hypoglycaemia.
Reddy M; Jugnee N; El Laboudi A; Spanudakis E; Anantharaja S; Oliver N
Diabet Med; 2018 Apr; 35(4):483-490. PubMed ID: 29230878
[TBL] [Abstract][Full Text] [Related]
18. Glucose Awareness to Motivate and Enable Solutions (GAMES) in diabetes mellitus using flash glucose monitoring: A clinical programme.
Yeoh E; Png D; Koh PL; Sum CF; Lim SC; Tan HH; Ubeynarayana CU; Subramaniam T
Diabet Med; 2022 Jan; 39(1):e14733. PubMed ID: 34698420
[TBL] [Abstract][Full Text] [Related]
19. Impact and duration effect of telemonitoring on ΗbA1c, BMI and cost in insulin-treated Diabetes Mellitus patients with inadequate glycemic control: A randomized controlled study.
Fountoulakis S; Papanastasiou L; Gryparis A; Markou A; Piaditis G
Hormones (Athens); 2015; 14(4):632-43. PubMed ID: 26188234
[TBL] [Abstract][Full Text] [Related]
20. Effect of the FreeStyle Libre™ flash glucose monitoring system on glycemic control in individuals with type 2 diabetes treated with basal-bolus insulin therapy: An open label, prospective, multicenter trial in Japan.
Ogawa W; Hirota Y; Osonoi T; Tosaki T; Kato Y; Utsunomiya K; Nishimura R; Nakamura J
J Diabetes Investig; 2021 Jan; 12(1):82-90. PubMed ID: 32562376
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]